Skip to main content

Table 5 Bivariate analysis of risk factors associated with Newborn prevalence of GBS, Hawassa University Comprehensive Specialized Hospital, November 2014–March 2015 (n = 280)

From: Prevalence of group B streptococcus among pregnant women and newborns at Hawassa University comprehensive specialized hospital, Hawassa, Ethiopia

Variables

Prevalence of GBS,

OR(95%CI)

P-value

Weight

1000-2499 g

3/32 (9.4%)

1.5 (0.27–9.11)

0.9

2500-4000 g+

23/260 (8.8%)

1

 

APGAR score at 5 min

< 7

11/131 (8.4%)

0.83 (0.37–1.9)

0.65

> 7

15/161 (9.3%)

1

 

Week of birth

< 37

3/28 (10.7%)

0.6 (0.05–7)

0.68

37–42

22/258 (8.5%)

0.47 (0.05–4.37)

0.55

> 42

1/6 (16.7%)

1

 

APGAR score at 10 min

< 7

5/35 (14.3%)

1.78 (0.62–5)

0.28

> 7

21/257 (8.6%)

1

 

Status of newborns at birth

Dead

2/12 (16.7%)

2.0 (0.42–9.8)

0.37

Alive

24/280 (8.6%)

1

 

Developed EOD

Yes

1/5 (20%)

2.5 (0.27–23.3)

0.42

No

25/287 (8.7%)

1

 

Other diseasea

Yes

4/13 (30.8%)

4.95 (1.41–17.3)

0.012

No

22/279 (7.9%)

1

 
  1. N total number of newborn, OR odds ratio, GBS group B Streptococcus, EOD early onset delivery, APGAR appearance, pulse, grimace, activity, respiration
  2. aOther disease include cyanosis, spinal bifida, hydrocephaly